Lumen Bioscience awarded $16.2 million to advance C. difficile treatment

by admin | Oct 17, 2023 | Press Release

Read More

Lumen Bioscience awarded $16.2 million in DoD funding to advance LMN-201 through late-stage trials

by admin | Oct 16, 2023 | Press Release

— Orally delivered biologic drug to treat and prevent C. difficile infection to start recruiting for late-stage trials in Q4 2023 Seattle, WA, October 17, 2023 – Lumen Bioscience—a clinical-stage biotechnology company developing biologic drugs for highly prevalent...

Cows Burp Out Too Much Methane. Lumen Bioscience is Making a Bovine Beano

by admin | Oct 11, 2023 | Press Release

Seattle-based biotech company Lumen Bioscience is working to reduce atmospheric harm by reducing cows’ methane emissions. The company is developing a manufactured enzyme to prevent cows’ digestive microorganisms from producing methane. Although Lumen typically makes...

Lumen Bioscience data show needle free spirulina-produced vaccination protects against malaria

by admin | Oct 4, 2023 | Press Release

Lumen Bioscience has published data demonstrating a needle-free, spirulina-produced recombinant vaccine that protects against malaria.  The research, conducted in collaboration with the University of Washington, was published in the peer-reviewed journal, Nature...

Belching cattle cause major damage to the climate. Here’s how a $1.5 million prize from the U. of U. could help change that

by admin | Oct 2, 2023 | Press Release

The University of Utah’s Wilkes Climate Center has awarded its first $1.5 million climate prize to a Seattle biotech firm, Lumen Bioscience, that has developed and patented enzymes that could potentially halve the climate-damaging methane that cows belch all day....

Cows burp out too much methane. This biotech startup is making a bovine Beano

by admin | Sep 26, 2023 | Press Release

Read More